These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1430905)

  • 1. [Post-menopausal osteoporosis. Epidemiologic aspects].
    Ringa V; Bréart G
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(6):607-15. PubMed ID: 1430905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fracture prevention in elderly women: treatment of osteoporosis is one approach, together with physical exercise and fall prevention.
    Prescrire Int; 1998 Oct; 7(37):155-9. PubMed ID: 10915424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporosis: new hope for the future.
    Masi L; Bilezikian JP
    Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of screening for osteoporosis in postmenopausal Japanese women.
    Nagata-Kobayashi S; Shimbo T; Fukui T
    J Bone Miner Metab; 2002; 20(6):350-7. PubMed ID: 12434163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of menopausal hormone therapy in preventing osteoporotic fractures: a critical review of the clinical evidence.
    Col NF; Bowlby LA; McGarry K
    Minerva Med; 2005 Oct; 96(5):331-42. PubMed ID: 16227948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone densitometry as a screening tool for osteoporosis in postmenopausal women.
    Radiol Manage; 1998; 20(2):43-54. PubMed ID: 10179192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk factors and prevention of postmenopausal osteoporosis].
    Orcel P
    Rev Prat; 1995 May; 45(9):1107-13. PubMed ID: 7792533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-thyroxin treatment and post-menopausal osteoporosis: relevance of the risk profile present in clinical history.
    La Vignera S; Vicari E; Tumino S; Ciotta L; Condorelli R; Vicari LO; Calogero AE
    Minerva Ginecol; 2008 Dec; 60(6):475-84. PubMed ID: 18981975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, etiology, and diagnosis of osteoporosis.
    Lane NE
    Am J Obstet Gynecol; 2006 Feb; 194(2 Suppl):S3-11. PubMed ID: 16448873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG
    CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic concepts in the treatment of postmenopausal osteoporosis].
    Leidig-Bruckner G; Ziegler R
    Ther Umsch; 1994 Nov; 51(11):737-47. PubMed ID: 7839332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Postmenopausal osteoporosis: how to detect women-at-risk?].
    Casez JP
    Schweiz Rundsch Med Prax; 1991 Apr; 80(16):428-30. PubMed ID: 2038640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO).
    Jakob F; Marín F; Martín-Mola E; Torgerson D; Fardellone P; Adami S; Thalassinos NC; Sykes D; Melo-Gomes J; Chinn C; Nicholson T; Cooper C
    QJM; 2006 Aug; 99(8):531-43. PubMed ID: 16861718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of osteoporosis and its economic aspects].
    Blachier C
    Cah Sociol Demogr Med; 1999; 39(2-3):271-82. PubMed ID: 10615567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indications and limitations of non-hormonal treatments of osteoporosis].
    Avouac B
    Rev Fr Gynecol Obstet; 1993; 88(7-9):419-23. PubMed ID: 8235256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical risk factors as predictors of postmenopausal osteoporosis in general practice.
    Versluis RG; Papapoulos SE; de Bock GH; Zwinderman AH; Petri H; van de Ven CM; Springer MP
    Br J Gen Pract; 2001 Oct; 51(471):806-10. PubMed ID: 11677703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density thresholds for pharmacological intervention to prevent fractures.
    Siris ES; Chen YT; Abbott TA; Barrett-Connor E; Miller PD; Wehren LE; Berger ML
    Arch Intern Med; 2004 May; 164(10):1108-12. PubMed ID: 15159268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.